Ellington Financial Inc

This non-binding advisory proposal asks stockholders to approve the compensation paid to the Company's named executive officers as disclosed in the proxy statement. Management is seeking this advisory endorsement to obtain stockholder feedback on its executive compensation practices even though the Company is externally managed and most named executive officers are employees of affiliates of the Manager or EMG. The Board explicitly notes that only the Chief Financial Officer and Chief Accounting Officer received compensation that the Company reimbursed under the management agreement, and that the vote is intended to address overall compensation policies and disclosure rather than a single cash item. The vote is advisory and not binding; however, the Compensation Committee will take the outcome into account when setting future compensation. Management recommends a vote FOR, arguing that the compensation structure provides appropriate alignment with stockholder interests and aids retention of key finance and accounting personnel. Company-specific context includes its external management structure, reimbursement mechanics for certain officers, and the fact that the Board has chosen to hold an annual advisory vote on compensation following prior stockholder input. Risks and criticisms that a sophisticated analyst should weigh include potential perceived conflicts from reimbursing Manager-paid compensation, dilution and incentive alignment given awards may be granted through plan structures, and that the advisory nature limits enforceability of stockholder preferences. The Board’s support, detailed disclosure of amounts reimbursed and equity awards, and historical vote results (e.g., ~87% support in 2025) suggest management expects and seeks continued stockholder endorsement while remaining responsive to stockholder feedback.

This management proposal requests stockholder approval of a broad equity incentive plan that would authorize 12,000,000 Common Shares (approximately 9.6% of outstanding shares as of the record date) for grant in various forms (options, SARs, restricted stock, RSUs, performance awards, LTIP Units, etc.) and is designed to replace the existing 2017 Plan. Management seeks approval to provide the Compensation Committee flexibility to grant equity awards to employees, officers, non-employee directors and service providers to recruit, retain, and align incentives with stockholder interests. Notable plan design features intended to mitigate common stockholder concerns include a double-trigger vesting acceleration upon a qualifying termination in connection with a change in control, conservative share recycling rules (excluding shares used for taxes, exercise price, or repurchases from being returned to the pool), a one-year minimum vesting requirement with limited enumerated exceptions, a prohibition on repricing options or SARs without stockholder approval, and an annual per-director equity limit of $750,000. The Company quantifies potential dilution (9.6% if approved) and explains that, while dilutive, the Board believes equity awards provide motivational and retention benefits. Contextual governance considerations for a sophisticated reviewer include the Company’s external management arrangement (awards can be granted to Manager-affiliated personnel and LTIP Units reduce the share reserve on a one-for-one basis), the replacement of the 2017 Plan (which would remain in force if this proposal fails), and the specific share-counting and recycling rules that are more conservative than some plans. The Board recommends FOR the plan, citing recruitment/retention, alignment with stockholders, and the enumerated governance protections; however, analysts should weigh the 9.6% authorized share amount, potential future award practices by the Compensation Committee, and the interplay between awards issued to Manager-affiliated personnel and stockholder interests. If stockholders do not approve the 2026 Plan, the 2017 Plan will remain in effect until it expires or its available shares are exhausted, constraining the Company's ability to grant additional equity under updated terms.